Nanomedicine and HIV symposium programme (Draft)




Venue: CSIR ICC, Ruby Auditorium, Pretoria

 Date: 05 and 06 December 2017; Time: 08:30-17:00.

08:00-08:50                                       Arrival and Registration
                         Programme Facilitator:  Dr Mthuthuzeli Zamxaka, SAASTA
Time Activity Presenter
09:00-09:10 Brief background of the symposium Dr Mthuthuzeli Zamxaka, SAASTA
09:10-09:25 NRF contributions  to TB and HIV/AIDS research in South Africa Dr Beverley Damonse, NRF
09:25-09:40 Address by Swiss Ambassador Ms Helene Budliger Artieda, Swiss
09:40-09:55 The current situation of  TB  and HIV/AIDS in South Africa Mr David Mametja, NDoH
09:55-10:20 Panel discussion ALL
10:20-10:40 Tea Break and Exhibition
Session Title: Policy Context for Utilisation of Nanomedicine in the Health sector

Session Objectives: Understanding the policy environment for nanomedicine  and its relevance to the health

sector in South Africa

Programme Facilitator:    Dr Beverley Damonse, NRF

10:40-10:55 Accelerating access to cheaper, better medicines using South African unique infrastructure Prof Francois Venter, Wits
10:55-11:10 The present and future projection of the use of Nanotechnology in solving global 21st challenges Prof Malik Maaza, UNISA
11:10-11:25 Nanotechnology: Research and postgraduate funding Dr Rakeshnie Ramoutar-Prieschl, NRF
11:25- 11:45 Panel discussion All
Session Title: Nanomedicine and  HIV/AIDS

Session Objective: Showcasing cutting-edge nanomedicine in HIV/AID research

Programme Facilitator:   Dr Admire Dube, UWC

11:45-12:00 Swiss-South Africa: HIV drug discovery researcher Dr Vinesh Maharaj, CSIR

Prof Thomas Klimkait, UNIBAS

12:00-12:15 Biological nanoparticles for the delivery of antibodies against HIV Dr Fiona van den Berg, NICD
12:15-12:30 Nanotherapeutics for the selective induction of apoptosis in targeted HIV infected cells Prof Mervin Meyer, UWC
12:30-12:45 Towards TB and HIV/AIDS diagnostic: A dendrimer-streptavidin supramolecular nano-architecture for electrochemical biosensor development Prof Omotayo Arotiba, UJ
12:45-13:10 Panel discussion ALL
13:10-14:10 Lunch Break and Exhibition
Session Title: Health Innovation

Session Objective: To highlight opportunities provided by SA and Swiss Embassy towards innovation support

Programme Facilitator: Dr Steven Mufamadi, Nabio Consulting

14:10-14:35 Health Innovation: DST strategy Dr Glaudina Loots, DST
14:35-14:50 Swiss innovation  challenge Mr Davis Cook, RIIS
14:50-15:05 Novartis and University of Basel Next Generation Scientist (NGS) programme Ms Akiko Keller, Novartis
15:05-15:30 Panel discussion ALL
15:30-15:45 Tea Break and Exhibition
Session Title:Pre-Clinical and Clinical Research Skills Shortage
Session Objective: SA and Swiss pre-clinical and clinical research skills programmes
Programme Facilitator:Prof Mervin Meyer,UWC
15:45-16:00 Pre-clinical and clinical development for nanopharmaceutics Prof Rose Hayeshi, NWU
16:00-16:15 HIV epitopes as candidates for drug and vaccine development Wolf-DieterSchubert, UP
Engagement Session: Take Home Messages
Session Objectives:  To highlight key messages and way forward from all the panel discussions
Programme Facilitator: Mr Michael  Ellis, SAASTA
16:15-16:50 Panel discussion: Symposium summary, key ideas and future developments
(Audience engagement through digital platform)
Panel: – One key speaker from each of the above sessions
16:50-17:00 Vote of thanks and announcement Ms Katlego Mokomo, Swiss
18:30-22:00 Cocktail & networking platform Swiss- SA Ambassador’s House


Programme Facilitator: Dr Mthuthuzeli Zamxaka, SAASTA
09:00-09:15 Technology Innovation & commercialisation support: Swiss-South Africa Business Development Programme (SSABDP) Ms Karen Eksteen, TIA
09:15-09:30 The Global Burden of TB and HIV/AIDS Dr Rufaro Chatora, WHO
09:30-09:45 Nanotechnology research and innovation: Swiss perspective Prof Edwin Constable, UNIBAS
09:45-10:10 Panel Discussion ALL
10:10 -10:30                                                  Tea Break and Exhibition
Session Title: Nanomedicine and TB

Session Objectives: Showcasing cutting-edge nanomedicine in TB research

Programme Facilitator: Dr Boitumelo Semete-Makokotlela, CSIR

10:30-10:45 Nanoparticle based immunotherapy for TB treatment Dr  Admire Dube, UWC
10:45-11:00 Inhalable nanomedicine – Pulmonary delivery of anti-TB drugs using pH responsive carriers Mr Mpho Ngoepe, Rhodes
11:00-11:15 Nanomedicine Training during Novartis and University of Basel next generation programme Dr Phuti Chelopo, CSIR
11:15 -11:50 Panel discussion  ALL
Session Title:  Manufacturing and Commercialisation  of Nanomaterials

Session Objectives: Nanomedicine manufacturing and commercialization supporting programme

Programme Facilitator: Dr Sibongile Gumbi, iVacBio

11:50-12:05 Amnis Imaging cytometry in the nanotechnology manufacturing Dr John Walters,  Merck
12:05-12:20 Entrepreneurs as the catalyst of nanomedicine commercialization Dr Steven Mufamadi, Nabio Consulting
12:20-12:35 DTI Perspective (Investments in Commercialising Innovative Research) Ms Nontombi Marule, TheDTI
12:35-13:00 Panel discussion ALL
13:00-14:00                                                                 Lunch Break and Exhibition
Session Title: Nanosafety Issues and Private Sector
Session Objective:  Understanding of the hazards of nanomaterials in health and private sector in TB and HIV/AIDS
Programme Facilitator:  Dr Patric Nkuna, CSIR
14:00-14:15 ACGT Health Biotechnology: TB and HIV/AIDS programmes Wolf-DieterSchubert, UP
14:15-14:30 Swiss private sector: Roche activities in South Africa Dr Nick Mangeya, Roche
14:30-14:45 ARV drug developed and manufactured in Africa Mr Stavros Nicolaou, Aspen
14:45-15:15 Panel discussion ALL
15:15-15:35                                                                 Tea Break and Exhibition
Session: Media and Public Engagement

Engagement Session: Take Home Messages

Session Objectives: To highlight key messages and way forward from all the panel discussions

Programme Facilitator: Mr Michael Ellis, SAASTA

15:35-15:50 Nanoscience education and public engagement platforms Mr Robert Inglis, JM
15:50-16:05 Science journalism Ms Ntando Makhuba,  The Star news
16:05-16:45 Panel discussion: Symposium summary, key ideas and future developments

(Audience engagement through digital platform)

Panel: One key speaker from each of the above sessions
16:45-16:55 Summary Prof  Edwin Constable, Swiss
16:55-17:00 Vote of thanks and announcement Ms Jacquelene Friedenthal, Swiss